Castle Biosciences (NASDAQ:CSTL – Get Free Report) will likely be posting its Q3 2025 results after the market closes on Monday, November 3rd. Analysts expect Castle Biosciences to post earnings of ($0.35) per share and revenue of$71.0620 million for the quarter. Castle Biosciences has set its FY 2025 guidance at EPS.Individuals can find conference call details on the company’s upcoming Q3 2025 earningreport page for the latest details on the call scheduled for Monday, November 3, 2025 at 4:30 PM ET. Get ...